Insider Buying: Artiva Biotherapeutics (NASDAQ:ARTV) Director Acquires 31,000 Shares
MarketBeat
Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) Director Ra Capital Management, L.P. acquired 31,000 shares of the business's stock in a transaction dated Thursday, June 25th. The stock was acquired at an average price of $8.88 per share, for a total transaction of $275,280.00. Following the completion of the transaction, the director owned 16,794,043 shares in the company, valued at approximately $149,131,101.84. The trade was a 0.18% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
NASDAQ:ARTV
